Previous studies have revealed heterogeneous cell populations even within the established cell lines [31–38], and our experiments with CDDP treatment studies also suggest that a subset of cells (e.g. putative cancer stem cells) are more resistant to drug treatment, and that GLI1 may play an important role in maintenance of this cell population. This evidence concerns the gene GLI1 and cancer.